Sep 14, 2018, 01:00 by admin admin

ASAM and the New York Society of Addiction Medicine (NYSAM) submitted comments on emergency proposed regulations to align state law with federal law to allow NPs and PAs to prescribe buprenorphine for addiction treatment.

Sep 14, 2018, 01:00 by admin admin

ASAM issued a letter of support for H.R. 4097, the Medicare Beneficiary Opioid Addiction Treatment Act, sponsored by Rep. Richard Neal. This legislation would modify the Medicare Part B program to permit Medicare coverage of methadone as an outpatient treatment for addiction. Currently, Medicare only covers methadone for inpatient use when used for addiction and is contrary to ASAM’s policy recommending that all public and private payers provide insurance coverage for the treatment of opioid addiction.

Sep 14, 2018, 01:00 by admin admin

ASAM led a coalition letter to HHS Secretary Tom Price expressing concern about comments he made in West Virginia suggesting that some forms of medication for opioid use disorder are superior to others, and that some are just replacing one opioid with another. The letter emphasizes how all three medications r approved by the FDA to treat opioid use disorder and are safe, effective, and help patients enter and sustain recovery and regain control of their lives.

Oct 3, 2017, 01:00 by admin admin

Newest update on opioid addiction- calls for a cultural shift in the way Americans talk about the opioid overdose crisis and recommends actions that can prevent and treat opioid use disorder and promote recovery.